Quick Takeaways
- CNMD - CONMED Corp financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q4 2025.
- Headline metric: Return On Invested Capital 3.6%.
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original FilingLatest SEC snapshot (2026-02-11) highlights Return On Invested Capital 3.6%, Return On Equity 4.7%, and Return On Assets 3.5%.
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
33.4/100
Weak Confidence high
3.6%
Metric score 0.0/100
4.7%
Metric score 0.0/100
3.5%
Metric score 18.4/100
Current Ratio and Quick Ratio
Return On Invested Capital, Return On Equity, and Return On Assets
Return On Invested Capital
3.6%
YoY: -59%
Return On Equity
4.7%
YoY: -68%
Industry median: -2.4% (n=46)
Return On Assets
3.5%
YoY: -65%
Industry median: -38% (n=46)
Operating Margin
7.3%
YoY: -51%
Industry median: -59% (n=32)
Current Ratio
2.14x
YoY: -7.2%
Industry median: 1.7x (n=46)
Quick Ratio
0.92x
YoY: -4.5%
Industry median: 1.04x (n=38)
Debt-to-equity
0.86x
YoY: -14%
Industry median: 0.8x (n=33)
Revenues YoY
5.2%
YoY:
Industry median: 18% (n=32)
NetIncomeLoss YoY
-64%
YoY:
Industry median: -12% (n=45)
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Invested Capital | 3.6% | -59% |
| Return On Equity | 4.7% | -68% |
| Return On Assets | 3.5% | -65% |
| Operating Margin | 7.2% | -51% |
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 2.14x | -7.2% |
| Quick Ratio | 0.92x | -4.5% |
| Debt-to-equity | 0.86x | -14% |
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | 5.2% | |
| NetIncomeLoss YoY | -64% |
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 30,833,536 | -0.24% |
| Common Stock, Value, Issued | $313,000 | 0% |
| Weighted Average Number of Shares Outstanding, Basic | 31,036,000 | +0.62% |
| Weighted Average Number of Shares Outstanding, Diluted | 31,149,000 | -0% |
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Metrics are computed with a market-consensus convention designed for cross-portal comparability.